Gwyneth Paltrow is once again at the center of social media buzz, for what fans believe may be a health-related device ...

Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as ...

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president, in addition to his ...

It projects a 23.1% growth rate over the next five ... We are upbeat about DexCom's continued strength in CGM products. In the first quarter, Dexcom’s G7 system continued its robust momentum.

Let’s do this over the next 12 months ... It offers various medical devices and products, including Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered ...

On April 16, CNBC reported that Trump’s tariffs are building a divide in the medical community. The first Trump administration did not impose tariffs on medical devices and protective gear ...

announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0% ...

RPGs Clair Obscur: Expedition 33's big Maelle nerf is even worse than we thought, as it turns out one of her best weapons was never meant to be so powerful in the first place RPGs Clair Obscur ...